These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 39116343)

  • 1. PTBP3 Mediates IL-18 Exon Skipping to Promote Immune Escape in Gallbladder Cancer.
    Zhao C; Zhao JW; Zhang YH; Zhu YD; Yang ZY; Liu SL; Tang QY; Yang Y; Wang HK; Shu YJ; Dong P; Wu XS; Gong W
    Adv Sci (Weinh); 2024 Aug; ():e2406633. PubMed ID: 39116343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NONO promotes gallbladder cancer cell proliferation by enhancing oncogenic RNA splicing of DLG1 through interaction with IGF2BP3/RBM14.
    Yang ZY; Zhao C; Liu SL; Pan LJ; Zhu YD; Zhao JW; Wang HK; Ye YY; Qiang J; Shi LQ; Mei JW; Xie Y; Gong W; Shu YJ; Dong P; Xiang SS
    Cancer Lett; 2024 Apr; 587():216703. PubMed ID: 38341127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypyrimidine tract-binding protein 3/insulin-like growth factor 2 mRNA-binding proteins 3/high-mobility group A1 axis promotes renal cancer growth and metastasis.
    Wang Q; Chen F; He Y; Gao Y; Wang J; Chu S; Xie P; Zhong J; Shan H; Bai J; Hou P
    iScience; 2024 Mar; 27(3):109158. PubMed ID: 38405614
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
    Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
    J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of polypyrimidine tract-binding protein 3 induces apoptosis and cell cycle arrest, and enhances the cytotoxicity of 5- fluorouracil in gastric cancer cells.
    Liang X; Shi H; Yang L; Qiu C; Lin S; Qi Y; Li J; Zhao A; Liu J
    Br J Cancer; 2017 Mar; 116(7):903-911. PubMed ID: 28222070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PTBP3 contributes to the metastasis of gastric cancer by mediating CAV1 alternative splicing.
    Liang X; Chen W; Shi H; Gu X; Li Y; Qi Y; Xu K; Zhao A; Liu J
    Cell Death Dis; 2018 May; 9(5):569. PubMed ID: 29752441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long non-coding RNA SLC25A21-AS1 inhibits the development of epithelial ovarian cancer by specifically inducing PTBP3 degradation.
    Li S; Shen S; Ge W; Cen Y; Zhang S; Cheng X; Wang X; Xie X; Lu W
    Biomark Res; 2023 Jan; 11(1):12. PubMed ID: 36717926
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612.
    Yang X; Qu S; Wang L; Zhang H; Yang Z; Wang J; Dai B; Tao K; Shang R; Liu Z; Li X; Zhang Z; Xia C; Ma B; Liu W; Li H; Dou K
    Oncogene; 2018 Dec; 37(50):6399-6413. PubMed ID: 30068940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PTBP3 modulates P53 expression and promotes colorectal cancer cell proliferation by maintaining UBE4A mRNA stability.
    Xie C; Long F; Li L; Li X; Ma M; Lu Z; Wu R; Zhang Y; Huang L; Chou J; Gong N; Hu G; Lin C
    Cell Death Dis; 2022 Feb; 13(2):128. PubMed ID: 35136024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PTBP3 promotes malignancy and hypoxia-induced chemoresistance in pancreatic cancer cells by ATG12 up-regulation.
    Ma J; Weng L; Jia Y; Liu B; Wu S; Xue L; Yin X; Mao A; Wang Z; Shang M
    J Cell Mol Med; 2020 Mar; 24(5):2917-2930. PubMed ID: 31989778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PTBP3-Mediated Regulation of ZEB1 mRNA Stability Promotes Epithelial-Mesenchymal Transition in Breast Cancer.
    Hou P; Li L; Chen F; Chen Y; Liu H; Li J; Bai J; Zheng J
    Cancer Res; 2018 Jan; 78(2):387-398. PubMed ID: 29187406
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surface PD-1 expression in T cells is suppressed by HNRNPK through an exonic splicing silencer on exon 3.
    Wang J; Yan L; Wang X; Jia R; Guo J
    Inflamm Res; 2024 Jul; 73(7):1123-1135. PubMed ID: 38698180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PTBP3 mediates TGF-β-induced EMT and metastasis of lung adenocarcinoma.
    Dong C; Wu K; Gu S; Wang W; Xie S; Zhou Y
    Cell Cycle; 2022 Jul; 21(13):1406-1421. PubMed ID: 35323096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of functionally distinct isoforms of PTBP3 by alternative splicing and translation initiation.
    Tan LY; Whitfield P; Llorian M; Monzon-Casanova E; Diaz-Munoz MD; Turner M; Smith CW
    Nucleic Acids Res; 2015 Jun; 43(11):5586-600. PubMed ID: 25940628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LPS Administration Impacts Glial Immune Programs by Alternative Splicing.
    Babenko VN; Shishkina GT; Lanshakov DA; Sukhareva EV; Dygalo NN
    Biomolecules; 2022 Feb; 12(2):. PubMed ID: 35204777
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTBP3 Induced Inhibition of Differentiation of Gastric Cancer Cells Through Alternative Splicing of Id1.
    Chen B; Chen W; Mu X; Yang L; Gu X; Zhao A; Liang X; Liu J
    Front Oncol; 2020; 10():1477. PubMed ID: 32974175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Insights Into PTBP3 in Human Cancers: Immune Cell Infiltration, TMB, MSI, PDCD1 and m6A Markers.
    Fang Z; Li P; Li H; Chong W; Li L; Shang L; Li F
    Front Pharmacol; 2022; 13():811338. PubMed ID: 35359851
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PTBP3 contributes to colorectal cancer growth and metastasis via translational activation of HIF-1α.
    Hou P; Chen F; Yong H; Lin T; Li J; Pan Y; Jiang T; Li M; Chen Y; Song J; Zheng J; Bai J
    J Exp Clin Cancer Res; 2019 Jul; 38(1):301. PubMed ID: 31291975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long noncoding RNA HEGBC promotes tumorigenesis and metastasis of gallbladder cancer via forming a positive feedback loop with IL-11/STAT3 signaling pathway.
    Yang L; Gao Q; Wu X; Feng F; Xu K
    J Exp Clin Cancer Res; 2018 Aug; 37(1):186. PubMed ID: 30086773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CLK1/SRSF5 pathway induces aberrant exon skipping of METTL14 and Cyclin L2 and promotes growth and metastasis of pancreatic cancer.
    Chen S; Yang C; Wang ZW; Hu JF; Pan JJ; Liao CY; Zhang JQ; Chen JZ; Huang Y; Huang L; Zhan Q; Tian YF; Shen BY; Wang YD
    J Hematol Oncol; 2021 Apr; 14(1):60. PubMed ID: 33849617
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.